Sandra Donnini Selected Research

Proteins (Proteins, Gene)

7/2022	ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade.
11/2020	Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells.
1/2019	miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction.
8/2018	Yeast-Derived Recombinant Avenanthramides Inhibit Proliferation, Migration and Epithelial Mesenchymal Transition of Colon Cancer Cells.
6/2017	Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells.
1/2015	Dbl oncogene expression in MCF-10 A epithelial cells disrupts mammary acinar architecture, induces EMT and angiogenic factor secretion.
4/2008	Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra Donnini Research Topics

Disease

34	Neoplasms (Cancer) 05/2024 - 01/2003
7	Hypoxia (Hypoxemia) 01/2021 - 07/2002
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 05/2017
5	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2020 - 07/2010
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2012 - 11/2004
4	Alzheimer Disease (Alzheimer's Disease) 11/2020 - 12/2004
4	Colonic Neoplasms (Colon Cancer) 08/2018 - 08/2010
3	Melanoma (Melanoma, Malignant) 05/2024 - 12/2019
3	Breast Neoplasms (Breast Cancer) 01/2020 - 12/2018
3	Pathologic Processes 01/2020 - 01/2004
3	Neoplasm Metastasis (Metastasis) 01/2015 - 03/2007
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2020
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2019
2	Inflammation (Inflammations) 01/2018 - 06/2015
2	Edema (Dropsy) 01/2018 - 01/2003
2	Prostatic Neoplasms (Prostate Cancer) 07/2016 - 08/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2016 - 03/2010
2	Stroke (Strokes) 01/2013 - 04/2009
1	Chronic Disease (Chronic Diseases) 11/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2020
1	Vascular Diseases (Vascular Disease) 03/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Pain (Aches) 01/2020
1	Cancer Pain 01/2020
1	Retinal Diseases 01/2018
1	Retinal Neovascularization 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Atherosclerosis 01/2018
1	Frailty 01/2018
1	Adenocarcinoma of Lung 05/2017

Drug/Important Bio-Agent (IBA)

11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2002
9	ErbB Receptors (EGF Receptor)IBA 01/2019 - 11/2004
7	Proteins (Proteins, Gene)FDA Link 07/2022 - 04/2008
7	ProstaglandinsIBA 06/2017 - 01/2008
6	EnzymesIBA 07/2022 - 11/2003
5	Amyloid (Amyloid Fibrils)IBA 11/2020 - 12/2004
5	Olive OilIBA 05/2020 - 08/2010
5	Dinoprostone (PGE2)FDA Link 01/2019 - 08/2007
5	Prostaglandins EIBA 01/2019 - 01/2008
5	Peptides (Polypeptides)IBA 01/2016 - 11/2003
4	PolyphenolsIBA 03/2020 - 08/2010
4	Prostaglandin-E SynthasesIBA 01/2019 - 08/2010
4	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2018 - 12/2004
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 01/2004
3	Angiogenesis InhibitorsIBA 10/2022 - 07/2004
3	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 03/2020 - 03/2016
3	Phosphotransferases (Kinase)IBA 03/2018 - 08/2010
3	Epidermal Growth Factor (EGF)IBA 03/2018 - 06/2017
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2017 - 07/2002
3	Amyloid beta-PeptidesIBA 07/2010 - 12/2004
2	Mitogen-Activated Protein KinasesIBA 05/2024 - 11/2004
2	Aldehyde DehydrogenaseIBA 05/2024 - 12/2018
2	Rituximab (Mabthera)FDA Link 01/2023 - 01/2020
2	AldehydesIBA 07/2022 - 12/2019
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 07/2002
2	AntioxidantsIBA 03/2020 - 03/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2019 - 08/2007
2	Protein Isoforms (Isoforms)IBA 01/2019 - 10/2002
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019 - 12/2018
2	Messenger RNA (mRNA)IBA 08/2018 - 07/2002
2	Cadherins (E-Cadherin)IBA 08/2018 - 06/2017
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2016 - 03/2010
2	Antineoplastic Agents (Antineoplastics)IBA 03/2016 - 01/2003
2	Cyclin-Dependent Kinase Inhibitor p21IBA 01/2016 - 01/2013
2	GalactosidasesIBA 01/2016 - 01/2013
2	Nitric Oxide Synthase (NO Synthase)IBA 08/2007 - 10/2002
2	pyrimidineIBA 03/2007 - 11/2004
2	src-Family KinasesIBA 03/2007 - 11/2004
1	trametinibIBA 05/2024
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2024
1	VemurafenibIBA 05/2024
1	Neutralizing AntibodiesIBA 07/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2020
1	Sulfates (Sulfates, Inorganic)IBA 03/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Morphine (MS Contin)FDA LinkGeneric 01/2020
1	Opioid Receptors (Opioid Receptor)IBA 01/2020
1	IsoenzymesIBA 12/2019
1	Oxidoreductases (Dehydrogenase)IBA 12/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Gefitinib (Iressa)FDA Link 01/2019
1	3' Untranslated Regions (3' UTR)IBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 03/2018
1	Dynamins (Dynamin)IBA 03/2018
1	CytokinesIBA 01/2018
1	Retinaldehyde (Retinal)IBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	KallidinIBA 01/2018
1	BradykininIBA 01/2018
1	Cetuximab (Erbitux)FDA Link 10/2017
1	VimentinIBA 06/2017
1	Tyrosine (L-Tyrosine)FDA Link 05/2017
1	LigandsIBA 05/2017
1	LectinsIBA 04/2017

Therapy/Procedure

9	Therapeutics 11/2022 - 01/2003
3	Drug Therapy (Chemotherapy) 12/2021 - 03/2016
1	Immunotherapy 01/2021
1	Lasers (Laser) 04/2017